ArticleDiabetology international2022
Documented contraceptive use after delivery in women with pre-gestational and gestational diabetes in Thailand: a single center study.
Article in Diabetology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.
- Beyond individual-level factors that influence family planning uptake among women with diabetes mellitus: a systematic literature review.BMC public health · 2025Pooled it
- Family planning behavior before and during the COVID-19 pandemic.Journal of the Turkish German Gynecological Association · 2024Article
- Reproductive care in Thai women with diabetes mellitus: a descriptive cross-sectional study.Reproductive health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To determine the contraceptive prevalence rate in postpartum women with diabetes complicating pregnancy. Materials and methods: This retrospective study included women diagnosed with gestational diabetes (GDM) and pre-existing diabetes (PDM) who delivered at Siriraj Hospital during January 2016 to December 2019. Contraceptive use during the 6 months postpartum period was reviewed and compared between the diabetes groups. Results: A total of 1539 women were enrolled, including 1466 women with GDM and 73 women with PDM. The overall contraceptive prevalence rate was 78.7%, which was not different between the diabetes groups (PDM 75.4% vs. GDM 78.9%, OR 0.95; 95% CI 0.83-1.09). The commonly used methods were sterilization (34.8%), progestin injection (15.2%) and condom (10.9%). Sterilization was more prevalent in PDM (PDM 56.2% vs. GDM 33.8%, OR 1.66; 95% CI 1.34-2.06) and a modern reversible method was infrequently used in women with PDM (PDM 19.2% vs. GDM 45.1%, OR 0.42; 95% CI 0.26-0.68). Among non-sterilization, the odds of contraceptive use was significantly lower in PDM (OR 0.64, 95% CI 0.43-0.95). Conclusions: Women with DM-complicated pregnancy frequently used contraception after delivery. However, the rate of modern contraceptive use among non-sterilized women was lower in those with PDM and the chosen methods were still inappropriate. Our findings highlight potential opportunities to improve contraceptive care and the need to promote the use of highly effective methods, seeking to minimize barriers for modern reversible contraceptive accessing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.